Physiological Changes Induced Through MEP Conditioning in People With SCI
Primary Purpose
Spinal Cord Injuries, Neurological Injury, Paralysis
Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Operant Conditioning
Control Group
Sponsored by
About this trial
This is an interventional treatment trial for Spinal Cord Injuries focused on measuring Corticospinal Tract, Neuroplasticity
Eligibility Criteria
Inclusion Criteria:
- Neurologically stable (>1 year post SCI)
- Medical clearance to participate
- Ability to ambulate at least 10 m with or without an assistive device (except for parallel bars)
- Signs of weak ankle dorsiflexion at least unilaterally
- Expectation that current medication will be maintained without change for at least 3 months; stable use of anti-spasticity medication is accepted
Exclusion Criteria:
- motoneuron injury
- known cardiac condition (e.g., history of myocardial infarction, congestive heart failure, pacemaker use)
- medically unstable condition
- cognitive impairment
- history of epileptic seizures
- metal implants in the cranium
- implanted biomedical device in or above the ches (e.g., a cardiac pacemaker, cochlear implant)
- no measurable MEP elicited
- unable to produce any voluntary TA EMG activity
- extensive use of functional electrical stimulation to the leg on a daily basis
- pregnancy (due to changes in weight and posture and potential medical instability)
Sites / Locations
- Medical University of South CarolinaRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Sham Comparator
Arm Label
Up-conditioning (UC) Group
Control (NC) Group
Arm Description
Outcomes
Primary Outcome Measures
Change in the excitability/strength of the brain-spinal cord-muscle pathway at the brain level as measured by the MEP recruitment curve--Studied Leg
An increased maximum MEP size (mV) would indicate increased excitability/strength of the brain-spinal cord-muscle pathway
Change in the cortical map of the Tibialis Anterior: identifying the size (cm2) of the area of the brain that controls the tibialis anterior, the muscle that raises the toes and foot--Studied Leg
Reorganization of the TA cortical map would suggest that operant conditioning of the muscle response changes the brain. Knowing if and how the brain changes will help investigators understand the potential impact of this type of training.
Change in the excitability/strength of the brain-spinal cord-muscle pathway at the spinal-cord level as measured by the Cervicomedullary MEP (CMEP) size--Studied Leg
An increase in the size of the CMEP (mV) elicited at a fixed stimulus intensity would indicate increased excitability/strength at the spinal cord level
Change in excitability of the excitability of the brain as measured by Short Interval Intra-cortical Inhibition (SICI)
Decreased SICI indicates increased excitability in the brain
Change in reflex activity as measured by the H-reflex amplitude (mV) in response to nerve stimulation--Studied Leg
Decreased H-reflex amplitude indicates reduced reflex activity and a more normal reflex response to muscle activity
Change in excitability/strength of the spinal cord-muscle pathway as measured by Change in F-wave amplitude (mV) and F-wave occurrence (out of 30 trials) in response to nerve stimulation--Studied Leg
Increased F-wave amplitude and/or occurrence indicates increased excitability/strength of the spinal cord-muscle pathway
Change in the ability to activate the muscle that lifts the toes during the swing-phase of walking as measured by tibialis anterior EMG amplitude (mv)--Studied Leg
Increased EMG amplitude indicates greater activation of the muscle, which could indicate an increased ability to lift the toes during the swing-phase of walking
Change in ankle joint motion during walking (deg)--Studied Leg
Ankle range of motion over the step cycle (in deg); Ankle peak flexion angle (in deg); Ankle angle at foot contact (in deg); Median ankle angle over the step cycle (in deg)
Change in walking speed (m/s) as measured by the 10-meter walk test
Speed of the participant's fastest comfortable walking speed across 10 meters. Decreased time (sec) demonstrates increased walking speed (m/s)
Change in walking distance (meters) as measured by the 6-minute walk test
The distance walked in 6 minutes in measured. The participant is asked to walk at his/her fastest comfortable speed on an indoor walkway.
Secondary Outcome Measures
Change in the excitability/strength of the brain-spinal cord-muscle pathway at the brain level as measured by the MEP recruitment curve--Contralateral Leg
An increased maximum MEP size (mV) would indicate increased excitability/strength of the brain-spinal cord-muscle pathway
Change in the cortical map of the Tibialis Anterior: identifying the size (cm2) of the area of the brain that controls the tibialis anterior, the muscle that raises the toes and foot--Contralateral Leg
Reorganization of the TA cortical map would suggest that operant conditioning of the muscle response changes the brain. Knowing if and how the brain changes will help investigators understand the potential impact of this type of training.
Change in the excitability/strength of the brain-spinal cord-muscle pathway at the spinal-cord level as measured by the Cervicomedullary MEP (CMEP) size--Contralateral Leg
An increase in the size of the CMEP (mV) elicited at a fixed stimulus intensity would indicate increased excitability/strength at the spinal cord level
Change in reflex activity as measured by the H-reflex amplitude (mV) in response to nerve stimulation--Contralateral Leg
Decreased H-reflex amplitude indicates reduced reflex activity and a more normal reflex response to muscle activity
Change in excitability/strength of the spinal cord-muscle pathway as measured by Change in F-wave amplitude (mV) and F-wave occurrence (out of 30 trials) in response to nerve stimulation--Contralateral Leg
Increased F-wave amplitude and/or occurrence indicates increased excitability/strength of the spinal cord-muscle pathway
Change in the ability to activate the muscle that lifts the toes during the swing-phase of walking as measured by tibialis anterior EMG amplitude (mv)--Contralateral Leg
Increased EMG amplitude indicates greater activation of the muscle, which could indicate an increased ability to lift the toes during the swing-phase of walking
Change in ankle joint motion during walking (deg)--Studied Leg
Ankle range of motion over the step cycle (in deg); Ankle peak flexion angle (in deg); Ankle angle at foot contact (in deg); Median ankle angle over the step cycle (in deg)
Change in knee joint motion during walking (deg)--Both Legs
Knee range of motion over the step cycle (in deg); knee peak flexion angle (in deg); knee peak extension angle (in deg); knee angle at foot contact (in deg); median knee angle over the step cycle (in deg)
Change in hip joint motion during walking (deg)--Both Legs
Hip range of motion over the step cycle (in deg); hip peak flexion angle (in deg); hip peak extension angle (in deg); hip angle at foot contact (in deg); median hip angle over the step cycle (in deg)
Changes in reflexes and muscle activation during walking as measured by H-reflex size and cutaneous reflex size
Decreased H-reflex response and decreased radiating threshold of the cutaneous reflex would reflect reflex activity that is more similar to individuals without neurological injury
Full Information
NCT ID
NCT04286191
First Posted
February 24, 2020
Last Updated
December 2, 2022
Sponsor
Medical University of South Carolina
Collaborators
National Institute of Neurological Disorders and Stroke (NINDS)
1. Study Identification
Unique Protocol Identification Number
NCT04286191
Brief Title
Physiological Changes Induced Through MEP Conditioning in People With SCI
Official Title
Characterization of Physiological Changes Induced Through Motor-evoked Potential Conditioning in People With Spinal Cord Injury
Study Type
Interventional
2. Study Status
Record Verification Date
December 2022
Overall Recruitment Status
Recruiting
Study Start Date
February 22, 2021 (Actual)
Primary Completion Date
November 30, 2024 (Anticipated)
Study Completion Date
November 30, 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Medical University of South Carolina
Collaborators
National Institute of Neurological Disorders and Stroke (NINDS)
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
No
5. Study Description
Brief Summary
The study team is currently recruiting volunteers who are interested in participating in a brain-spinal cord-muscle response training study that aims to better understand the changes that take place in the nervous system as a result of this type of training. After spinal cord injury, brain-to-muscle connections are often interrupted. Because these connections are important in movement control, when they are not working well, movements may be disturbed. Researchers have found that people can learn to strengthen these connections through training. Strengthening these connections may be able to improve movement control and recovery after injuries.
Research participants will be asked to stand, sit, and walk during the study sessions. Electrodes are placed on the skin over leg muscles for monitoring muscle activity. For examining brain-to-muscle connections, the study team will use transcranial magnetic stimulation. The stimulation is applied over the head and will indirectly stimulate brain cells with little or no discomfort.
Participation in this study requires approximately three sessions per week for four months, followed by two to three sessions over another three months. Each session lasts approximately 1 hour.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Spinal Cord Injuries, Neurological Injury, Paralysis, Spasticity, Muscle
Keywords
Corticospinal Tract, Neuroplasticity
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
44 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Up-conditioning (UC) Group
Arm Type
Experimental
Arm Title
Control (NC) Group
Arm Type
Sham Comparator
Intervention Type
Combination Product
Intervention Name(s)
Operant Conditioning
Intervention Description
This is a training intervention in which the brain-spinal cord-muscle pathways are strengthened in individuals with incomplete spinal cord injury. Transcranial magnetic stimulation (TMS), a type of brain stimulation, will be used to elicit a muscle response from the tibialis anterior (TA), the muscle that lifts your toes and foot.
Intervention Type
Combination Product
Intervention Name(s)
Control Group
Intervention Description
This is the control intervention, or the non-conditioning group. Transcranial magnetic stimulation (TMS), a type of brain stimulation, will be used to elicit a muscle response from the tibialis anterior (TA), the muscle that lifts your toes and foot.
Primary Outcome Measure Information:
Title
Change in the excitability/strength of the brain-spinal cord-muscle pathway at the brain level as measured by the MEP recruitment curve--Studied Leg
Description
An increased maximum MEP size (mV) would indicate increased excitability/strength of the brain-spinal cord-muscle pathway
Time Frame
Baseline through 3 months post intervention
Title
Change in the cortical map of the Tibialis Anterior: identifying the size (cm2) of the area of the brain that controls the tibialis anterior, the muscle that raises the toes and foot--Studied Leg
Description
Reorganization of the TA cortical map would suggest that operant conditioning of the muscle response changes the brain. Knowing if and how the brain changes will help investigators understand the potential impact of this type of training.
Time Frame
Baseline through 3 months post intervention
Title
Change in the excitability/strength of the brain-spinal cord-muscle pathway at the spinal-cord level as measured by the Cervicomedullary MEP (CMEP) size--Studied Leg
Description
An increase in the size of the CMEP (mV) elicited at a fixed stimulus intensity would indicate increased excitability/strength at the spinal cord level
Time Frame
Baseline through 3 months post intervention
Title
Change in excitability of the excitability of the brain as measured by Short Interval Intra-cortical Inhibition (SICI)
Description
Decreased SICI indicates increased excitability in the brain
Time Frame
Baseline through 3 months post intervention
Title
Change in reflex activity as measured by the H-reflex amplitude (mV) in response to nerve stimulation--Studied Leg
Description
Decreased H-reflex amplitude indicates reduced reflex activity and a more normal reflex response to muscle activity
Time Frame
Baseline through 3 months post intervention
Title
Change in excitability/strength of the spinal cord-muscle pathway as measured by Change in F-wave amplitude (mV) and F-wave occurrence (out of 30 trials) in response to nerve stimulation--Studied Leg
Description
Increased F-wave amplitude and/or occurrence indicates increased excitability/strength of the spinal cord-muscle pathway
Time Frame
Baseline through 3 months post intervention
Title
Change in the ability to activate the muscle that lifts the toes during the swing-phase of walking as measured by tibialis anterior EMG amplitude (mv)--Studied Leg
Description
Increased EMG amplitude indicates greater activation of the muscle, which could indicate an increased ability to lift the toes during the swing-phase of walking
Time Frame
Baseline through 3 months post intervention
Title
Change in ankle joint motion during walking (deg)--Studied Leg
Description
Ankle range of motion over the step cycle (in deg); Ankle peak flexion angle (in deg); Ankle angle at foot contact (in deg); Median ankle angle over the step cycle (in deg)
Time Frame
Baseline through 3 months post intervention
Title
Change in walking speed (m/s) as measured by the 10-meter walk test
Description
Speed of the participant's fastest comfortable walking speed across 10 meters. Decreased time (sec) demonstrates increased walking speed (m/s)
Time Frame
Baseline through 3 months post intervention
Title
Change in walking distance (meters) as measured by the 6-minute walk test
Description
The distance walked in 6 minutes in measured. The participant is asked to walk at his/her fastest comfortable speed on an indoor walkway.
Time Frame
Baseline through 3 months post intervention
Secondary Outcome Measure Information:
Title
Change in the excitability/strength of the brain-spinal cord-muscle pathway at the brain level as measured by the MEP recruitment curve--Contralateral Leg
Description
An increased maximum MEP size (mV) would indicate increased excitability/strength of the brain-spinal cord-muscle pathway
Time Frame
Baseline through 3 months post intervention
Title
Change in the cortical map of the Tibialis Anterior: identifying the size (cm2) of the area of the brain that controls the tibialis anterior, the muscle that raises the toes and foot--Contralateral Leg
Description
Reorganization of the TA cortical map would suggest that operant conditioning of the muscle response changes the brain. Knowing if and how the brain changes will help investigators understand the potential impact of this type of training.
Time Frame
Baseline through 3 months post intervention
Title
Change in the excitability/strength of the brain-spinal cord-muscle pathway at the spinal-cord level as measured by the Cervicomedullary MEP (CMEP) size--Contralateral Leg
Description
An increase in the size of the CMEP (mV) elicited at a fixed stimulus intensity would indicate increased excitability/strength at the spinal cord level
Time Frame
Baseline through 3 months post intervention
Title
Change in reflex activity as measured by the H-reflex amplitude (mV) in response to nerve stimulation--Contralateral Leg
Description
Decreased H-reflex amplitude indicates reduced reflex activity and a more normal reflex response to muscle activity
Time Frame
Baseline through 3 months post intervention
Title
Change in excitability/strength of the spinal cord-muscle pathway as measured by Change in F-wave amplitude (mV) and F-wave occurrence (out of 30 trials) in response to nerve stimulation--Contralateral Leg
Description
Increased F-wave amplitude and/or occurrence indicates increased excitability/strength of the spinal cord-muscle pathway
Time Frame
Baseline through 3 months post intervention
Title
Change in the ability to activate the muscle that lifts the toes during the swing-phase of walking as measured by tibialis anterior EMG amplitude (mv)--Contralateral Leg
Description
Increased EMG amplitude indicates greater activation of the muscle, which could indicate an increased ability to lift the toes during the swing-phase of walking
Time Frame
Baseline through 3 months post intervention
Title
Change in ankle joint motion during walking (deg)--Studied Leg
Description
Ankle range of motion over the step cycle (in deg); Ankle peak flexion angle (in deg); Ankle angle at foot contact (in deg); Median ankle angle over the step cycle (in deg)
Time Frame
Baseline through 3 months post intervention
Title
Change in knee joint motion during walking (deg)--Both Legs
Description
Knee range of motion over the step cycle (in deg); knee peak flexion angle (in deg); knee peak extension angle (in deg); knee angle at foot contact (in deg); median knee angle over the step cycle (in deg)
Time Frame
Baseline through 3 months post intervention
Title
Change in hip joint motion during walking (deg)--Both Legs
Description
Hip range of motion over the step cycle (in deg); hip peak flexion angle (in deg); hip peak extension angle (in deg); hip angle at foot contact (in deg); median hip angle over the step cycle (in deg)
Time Frame
Baseline through 3 months post intervention
Title
Changes in reflexes and muscle activation during walking as measured by H-reflex size and cutaneous reflex size
Description
Decreased H-reflex response and decreased radiating threshold of the cutaneous reflex would reflect reflex activity that is more similar to individuals without neurological injury
Time Frame
Baseline through 3 months post intervention
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Neurologically stable (>1 year post SCI)
Medical clearance to participate
Ability to ambulate at least 10 m with or without an assistive device (except for parallel bars)
Signs of weak ankle dorsiflexion at least unilaterally
Expectation that current medication will be maintained without change for at least 3 months; stable use of anti-spasticity medication is accepted
Exclusion Criteria:
motoneuron injury
known cardiac condition (e.g., history of myocardial infarction, congestive heart failure, pacemaker use)
medically unstable condition
cognitive impairment
history of epileptic seizures
metal implants in the cranium
implanted biomedical device in or above the ches (e.g., a cardiac pacemaker, cochlear implant)
no measurable MEP elicited
unable to produce any voluntary TA EMG activity
extensive use of functional electrical stimulation to the leg on a daily basis
pregnancy (due to changes in weight and posture and potential medical instability)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Blair Dellenbach, MSOT
Phone
843-792-6313
Email
stecb@musc.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Aiko K Thompson, PhD
Organizational Affiliation
Medical University of South Carolina
Official's Role
Principal Investigator
Facility Information:
Facility Name
Medical University of South Carolina
City
Charleston
State/Province
South Carolina
ZIP/Postal Code
29425
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Blair Dellenbach
Phone
843-792-6313
Email
stecb@musc.edu
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Physiological Changes Induced Through MEP Conditioning in People With SCI
We'll reach out to this number within 24 hrs